Investment firm raises $500M to target healthcare innovation

Investment firm B Capital closed its inaugural $500 million B Capital Healthcare Fund I; the fund will target all sectors of healthcare, from biotech to digital health.

Advertisement

With the closure of this fund, B Capital now has $6.3 billion in assets under management. Currently, the team’s healthcare portfolio includes over 20 healthcare companies, according to a March 1 B Capital news release.

“We are witnessing unprecedented innovation across the healthcare landscape,” Robert Mittendorff, MD, general partner and head of healthcare at B Capital, said in the release. “Technological advancements in biology, artificial intelligence and automation are transforming the industry, with business models seeing the convergence of traditional players in novel ways. This moment presents a unique opportunity for B Capital to leverage our dedicated healthcare capital and active investment strategy to find and support companies advancing the healthcare sector.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.